Literature DB >> 21319839

Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

Kaylin M McMahon1, R Kannan Mutharasan, Sushant Tripathy, Dorina Veliceasa, Mariana Bobeica, Dale K Shumaker, Andrea J Luthi, Brian T Helfand, Hossein Ardehali, Chad A Mirkin, Olga Volpert, C Shad Thaxton.   

Abstract

We report a gold nanoparticle-templated high density lipoprotein (HDL AuNP) platform for gene therapy that combines lipid-based nucleic acid transfection strategies with HDL biomimicry. For proof-of-concept, HDL AuNPs are shown to adsorb antisense cholesterylated DNA. The conjugates are internalized by human cells, can be tracked within cells using transmission electron microscopy, and regulate target gene expression. Overall, the ability to directly image the AuNP core within cells, the chemical tailorability of the HDL AuNP platform, and the potential for cell-specific targeting afforded by HDL biomimicry make this platform appealing for nucleic acid delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21319839      PMCID: PMC4077779          DOI: 10.1021/nl1041947

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  50 in total

1.  All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

Authors:  Amareshwar T K Singh; Andrew M Evens; Reilly J Anderson; Jennifer A Beckstead; Natesan Sankar; Antonella Sassano; Savita Bhalla; Shuo Yang; Leonidas C Platanias; Trudy M Forte; Robert O Ryan; Leo I Gordon
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

Review 2.  Lipidic systems for in vivo siRNA delivery.

Authors:  Sherry Y Wu; Nigel A J McMillan
Journal:  AAPS J       Date:  2009-09-09       Impact factor: 4.009

Review 3.  Nanoparticle technologies for cancer therapy.

Authors:  Frank Alexis; Eric M Pridgen; Robert Langer; Omid C Farokhzad
Journal:  Handb Exp Pharmacol       Date:  2010

Review 4.  Reverse cholesterol transport and cholesterol efflux in atherosclerosis.

Authors:  R Ohashi; H Mu; X Wang; Q Yao; C Chen
Journal:  QJM       Date:  2005-10-28

5.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

6.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.

Authors:  Sebastien Spagnou; Andrew D Miller; Michael Keller
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

8.  Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.

Authors:  Carlos G Leon; Jennifer A Locke; Hans H Adomat; Susan L Etinger; Alexis L Twiddy; Rachel D Neumann; Colleen C Nelson; Emma S Guns; Kishor M Wasan
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

9.  mir-210: a sensor for hypoxic stress during tumorigenesis.

Authors:  Lijoy K Mathew; M Celeste Simon
Journal:  Mol Cell       Date:  2009-09-24       Impact factor: 17.970

10.  miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.

Authors:  Antonis Giannakakis; Raphael Sandaltzopoulos; Joel Greshock; Shun Liang; Jia Huang; Kosei Hasegawa; Chunsheng Li; Ann O'Brien-Jenkins; Dionyssios Katsaros; Barbara L Weber; Celeste Simon; George Coukos; Lin Zhang
Journal:  Cancer Biol Ther       Date:  2007-11-14       Impact factor: 4.742

View more
  53 in total

Review 1.  Gold nanoparticles: preparation, properties, and applications in bionanotechnology.

Authors:  Yi-Cheun Yeh; Brian Creran; Vincent M Rotello
Journal:  Nanoscale       Date:  2011-11-10       Impact factor: 7.790

Review 2.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

3.  Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles.

Authors:  Kaylin M McMahon; Michael P Plebanek; C Shad Thaxton
Journal:  Adv Funct Mater       Date:  2016-09-20       Impact factor: 18.808

4.  Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.

Authors:  Aneta J Mieszawska; YongTae Kim; Anita Gianella; Inge van Rooy; Bram Priem; Matthew P Labarre; Canturk Ozcan; David P Cormode; Artiom Petrov; Robert Langer; Omid C Farokhzad; Zahi A Fayad; Willem J M Mulder
Journal:  Bioconjug Chem       Date:  2013-08-21       Impact factor: 4.774

Review 5.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis.

Authors:  Mark E Lobatto; Valentin Fuster; Zahi A Fayad; Willem J M Mulder
Journal:  Nat Rev Drug Discov       Date:  2011-10-21       Impact factor: 84.694

6.  Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds.

Authors:  Stephen E Henrich; Bong Jin Hong; Jonathan S Rink; SonBinh T Nguyen; C Shad Thaxton
Journal:  J Am Chem Soc       Date:  2019-06-13       Impact factor: 15.419

Review 7.  Hybrid lipid-nanoparticle complexes for biomedical applications.

Authors:  Kevin M Vargas; Young-Seok Shon
Journal:  J Mater Chem B       Date:  2019-01-03       Impact factor: 6.331

Review 8.  Synthetic high-density lipoprotein-like nanoparticles for cancer therapy.

Authors:  Linda Foit; Francis J Giles; Leo I Gordon; Colby Shad Thaxton
Journal:  Expert Rev Anticancer Ther       Date:  2014-12-09       Impact factor: 4.512

Review 9.  Update on current and potential nanoparticle cancer therapies.

Authors:  Jonathan S Rink; Michael P Plebanek; Sushant Tripathy; C Shad Thaxton
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

10.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.